Highlights from the World Congress of Neurology in Kyoto, Japan
Category: Industry News
Epistatus® 10 mg Oromucosal Solution Midazolam – Now Available To Prescribe
Press release on behalf of Special Products Ltd
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years
Press release on behalf of Merck
Real-world data confirms clinical effectiveness of Zebinix®
Press release on behalf of Eisai and Bial
European Commission Grants Approval for Mavenclad (Cladribine Tablets)
First oral short-course treatment for highly active relapsing multiple sclerosis (RMS) now approved in Europe
MasterClass on the non-oral therapies and new NICE guideline for Parkinson’s
With publication of the new NICE guideline for Parkinson’s, Parkinson’s Academy is holding a series of roadshows exploring the non-oral therapy pathway in detail
Roche’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis
News from Roche at the EAN congress
Data Provide Insight into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients with Relapsing MS
News from Merck at the EAN congress
Highlights from the EAN in Amsterdam
Read about the highlights from the recent European Academy of Neurology congress in Amsterdam
